Invesaro

Stocks Health care SOLV

NYSE · Health care

Solventum Corp (SOLV)

Solventum Corp brought in $8.3B of revenue over the twelve months to June 30, 2026, down 0.9% from a year earlier. Net income was $1.4B, a net margin of 17.3%. In fiscal 2025 capital spending exceeded operating cash flow by $10M. At June 30, 2026 it held $403M in cash against $4.6B of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 5, 2026.

Price
$89.50
+1.03% on the day · September 25, 2026
52-week range $62.38 to $94.16
Market cap
$15.2B
Revenue (last 12 months)
$8.3B
-0.9% year on year
Net margin
17.3%
P/E
10.1
on FY2025 diluted EPS

What Solventum Corp does

Solventum Corp is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NYSE under the ticker SOLV.

Revenue and profit by year

Revenue
FY22: $8.1B $8.1B FY22FY24: $8.2B $8.2B FY24FY24: $8.3B $8.3B FY24FY25: $8.3B $8.3B FY25
Net income
FY22: $1.3B $1.3B FY22FY24: $1.3B $1.3B FY24FY24: $479M $479M FY24FY25: $1.6B $1.6B FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$8.3B$2.2B$1.6B$8.88-$10M
2024$8.3B$1B$479M$2.76$805M
2024$8.2B$1.7B$1.3B$7.79$1.6B
2022$8.1B$1.7B$1.3B$7.78$1.4B

Latest SEC filings

What Solventum Corp has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. August 5, 2026
    Quarterly report 10-Q · period to June 30, 2026
  2. August 5, 2026
    Quarterly results 8-K
  3. August 5, 2026
    Investor disclosure 8-K
  4. July 20, 2026
    Executive or director change 8-K
  5. June 5, 2026
    Other event 8-K
  6. May 29, 2026
    Conflict minerals disclosure SD
  7. May 27, 2026
    Executive or director change 8-K
  8. May 20, 2026
    Shareholder vote results 8-K
  9. May 5, 2026
    Quarterly report 10-Q · period to March 31, 2026
  10. May 5, 2026
    Quarterly results 8-K

Recent insider filings (Forms 3, 4 and 144): 10, the latest on September 3, 2026. Insider transactions on SEC

All filings on SEC EDGAR

Questions about SOLV

What does Solventum Corp do?

Solventum Corp is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NYSE under the ticker SOLV.

Is Solventum Corp profitable?

Yes. Over the twelve months to June 30, 2026 it reported net income of $1.4B on revenue of $8.3B, a net margin of 17.3%.

How much revenue does Solventum Corp make?

Over the twelve months to June 30, 2026 Solventum Corp reported revenue of $8.3B. That is 0.9% less than a year earlier.

When did Solventum Corp last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 5, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the insider trade from September 3, 2026.

Similar companies

MDLN
Medline Inc.
SYK
Stryker Corp
MMM
3M Co
BDX
Becton Dickinson & Co
BSX
Boston Scientific Corp
BAX
Baxter International Inc

Follow SOLV

Get an email when Solventum Corp files with the SEC: results, executive changes, material agreements and annual reports.

Follow SOLV: get an email when it files

Where the numbers come from

Financial figures are the values Solventum Corp tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.